With a 6-4 vote, the group of independent advisers to the agency narrowly concluded that results from another clinical trial are needed to assess whether the therapy, called AMX0035, can help patients.
Author: PAM BELLUCK
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}